PRVA files Form 144 to sell 600 vested shares

PRVA submitted a Form 144 notice for the proposed sale of 600 shares of Common Stock tied to a restricted stock vesting event on 03/11/2026.

Rhea-AI Filing Summary

PRVA submitted a Form 144 notice for the proposed sale of 600 shares of Common Stock tied to a restricted stock vesting event on 03/11/2026. The filing also lists multiple sales by David Mountcastle between 05/01/2026 and 07/02/2026, including 24,734 shares sold on 07/02/2026.

The 144 lists the selling broker as Fidelity Brokerage Services LLC and shows compensation-related vesting as the source of the 600 shares to be sold. Transaction proceeds for recent sales are shown in the filing alongside sale dates and share counts.

Insights

Securities Compliance Analyst

Form 144 reports a proposed resale and several recent insider sales by a single holder.

The filing records a proposed sale of 600 shares tied to Restricted Stock Vesting dated 03/11/2026, and lists multiple completed sales by David Mountcastle between 05/01/2026 and 07/02/2026. The broker named is Fidelity Brokerage Services LLC.

These entries are routine compliance disclosures under Rule 144. Cash-flow treatment is shown as proceeds per transaction lines; timing and execution details beyond dates and amounts are not provided in the excerpt.

Key Figures

Proposed resale: 600 shares Sale on 07/02/2026: 24,734 shares Proceeds on 07/02/2026: $680,187.50 +3 more

6 metrics

Proposed resale 600 shares restricted stock vesting on <date>03/11/2026</date>

Sale on 07/02/2026 24,734 shares reported sale by David Mountcastle on <date>07/02/2026</date>

Proceeds on 07/02/2026 $680,187.50 proceeds reported for 24,734-share sale on <date>07/02/2026</date>

Sale on 06/26/2026 17,196 shares reported sale by David Mountcastle on <date>06/26/2026</date>

Proceeds on 06/26/2026 $433,036.65 proceeds reported for 17,196-share sale on <date>06/26/2026</date>

Earlier sales listed 7,179; 1,206; 3,385 shares sales on <date>05/01/2026</date>, <date>05/04/2026</date>, <date>05/11/2026</date>

Key Terms

Form 144, Restricted Stock Vesting, Proceeds

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Restricted Stock Vesting | Issuer | 600 | 03/11/2026"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Proceeds financial

"24734 | 680187.50 144: Remarks and Signature"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does PRVA's Form 144 disclose?

It discloses a proposed resale of 600 shares from restricted stock vesting and several recent sales by an insider. The filing lists a 600-share vesting event dated 03/11/2026 and multiple sales by David Mountcastle between 05/01/2026 and 07/02/2026, including share counts and proceeds.

Who is the selling party named in the PRVA Form 144?

David Mountcastle is the individual linked to the reported sales and the filing lists Fidelity Brokerage Services LLC as broker. The filing shows Mountcastle's address and multiple sale dates with share counts and proceeds.

How many shares are proposed for resale under the vesting entry?

The filing lists 600 shares tied to a restricted stock vesting event dated 03/11/2026. That 600-share item is labeled in the excerpt as originating from compensation-related restricted stock vesting.

What recent insider sales are shown in the excerpt for PRVA?

The excerpt lists sales on 05/01/2026, 05/04/2026, 05/11/2026, 06/26/2026, and 07/02/2026. Notable entries include 17,196 shares on 06/26/2026 and 24,734 shares on 07/02/2026 with corresponding proceeds.

Does the Form 144 indicate who receives the sale proceeds?

The filing shows proceeds per transaction lines but does not reassign proceeds to a party beyond the seller entries. Each sale line in the excerpt lists a dollar amount of proceeds next to the sale date and share count.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/07/2026 - 03:57 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001858396
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Privia Health Group, Inc.
SEC File Number	001-40365
Address of Issuer	950 N. GLEBE RD., SUITE 700 ARLINGTON VIRGINIA 22203
Phone	571-366-8850
Name of Person for Whose Account the Securities are To Be Sold	Mountcastle David
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	600	16539.00	126012374	07/07/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/11/2026	Restricted Stock Vesting	Issuer			600	03/11/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	05/01/2026	7179	179680.74
David Mountcastle 950 N. Glebe Rd Suite 700 Arlington VA 22203	Common	05/04/2026	1206	30150.00
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	05/11/2026	3385	76512.85
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	06/26/2026	17196	433036.65
David Mountcastle 950 N. Glebe Rd. Suite 700 Arlington VA 22203	Common	07/02/2026	24734	680187.50

144: Remarks and Signature

Remarks
Date of Notice	07/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/13/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gary Redman, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for David Mountcastle
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)